« A disruptive technology, which can be applied in the treatment of numerous conditions »
> Press releases 2023
THERANEXUS publishes its cash position as of 31 December 2022 and announces organizational changes
18/01/2023 before market opens
(<1Mo)
New advance to the Theranexus and BBDF Batten-1 program for juvenile Batten disease (CLN3)
05/01/2023
(<1Mo)